Receive up-to-the-minute news updates on the hottest topics with NewsHub. Install now.

Aphria shares slip as investment firm hits back at short-sellers’ allegations

December 5, 2018 4:54 PM
119 0

Quintessential Capital Management and Hindenburg Research alleged Monday that Aphria’s recent acquisitions of assets in Colombia, Argentina and Jamaica from Scythian Biosciences are “largely worthless” and bought in ways that the short-sellers believe benefit a group of insiders.

Scythian, now called Toronto-based SOL Global Investments Corp., says it is “satisfied” with the outcome and that the transaction completed in September was “thoroughly reviewed by both parties.”

SOL also says it will form a special board committee and engage independent counsel to review the short sellers’ allegations and “pursue all available legal relief.”


Share in social networks:

Comments - 0